György Sölétormos

Author

György Sölétormos

Also Known As

G Söletormos, G Sölétormos, G. SOLETORMOS, G. Soletormos, G. SÖLÉTORMOS, G. SöLétormos, G. Söletormos, G. Sölétormos, Georg Soletormos, György Sölétormos

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

University of Copenhagen Herlev Hospital Zealand University Hospital Rigshospitalet Nordsjællands Hospital

About

György Sölétormos is an author at University of Copenhagen specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	608
2	Engineering	5	5	163
3	Public Health	5	5	139
4	Health Sciences	2	2	55
5	Education	1	1	18

György Sölétormos

Publications

Citations

H-Index

Page 1

	Year	Citations
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers Catharine M. Sturgeon, Michael J. Duffy, Ulf‐Håkan Stenman, Clinical Chemistry	2008	1.1K
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use Michael J. Duffy, J. M. G. Bonfrer, J Kulpa, International Journal of Gynecological Cancer	2005	297
Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer György Sölétormos, Michael J. Duffy, Suher Othman Abu Hassan, International Journal of Gynecological Cancer	2015	258
Abnormal vital signs are strong predictors for intensive care unit admission and in-hospital mortality in adults triaged in the emergency department - a prospective cohort study Charlotte Barfod, Marlene Mauson Pankoke Lauritzen, Jakob Danker, Scandinavian Journal of Trauma Resuscitation and Emergency Medicine	2012	190
Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy Malgorzata Tuxen, György Sölétormos, P Dombernowsky British Journal of Cancer	2001	67
Monitoring different stages of breast cancer using tumour markers CA 15-3, CEA and TPA György Sölétormos, Dorte Nielsen, Vibeke Schiøler, European Journal of Cancer Tumor BiologyBreast OncologyCancer DetectionMedicinePathology	2003	62
Interpretation of results for tumor markers on the basis of analytical imprecision and biological variation György Sölétormos, Vibeke Schiøler, Dorte Nielsen, Clinical Chemistry Analytical ImprecisionEngineeringPathologyTumor BiologyTumor Markers	1993	62
In vitro detection of circulating tumor cells compared by the CytoTrack and CellSearch methods Thore Hillig, Peer Horn, Ann‐Britt Nygaard, Tumor Biology	2015	58
Assessment of Biological Variation and Analytical Imprecision of CA 125, CEA, and TPA in Relation to Monitoring of Ovarian Cancer Malgorzata Tuxen, György Sölétormos, Per Hyltoft Petersen, Gynecologic Oncology RadiologyCa 125Cancer DetectionMedicineGynecology	1999	56
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use Michael J. Duffy, Johannes M.G. Bonfrèr, J Kulpa, International Journal of Gynecological Cancer	2005	56

Page 1